Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
CheckMate 025 Randomized Phase 3 Study: Outcomes by Key B... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma
0
Authors
Bernard Escudier
19 more
Bernard Escudier
•
Ian Waxman
17 more
•
Robert Motzer
Published
March 3, 2017
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
European Urology
Topics
Medicine
Cancer Oncology
Internal Medicine
Urology
Pulmonary And Respiratory Medicine
Show all topics
DOI
10.1016/j.eururo.2017.02.010